NVAX Financial Facts
Revenue: 3.44MResearch and development: 9.43M
See Full Income Statement
Cash and cash equivalents: 9.02M
Additional paid-in capital: 446.19M
See Full Balance Sheet
Earnings History for Novavax, Inc. (NVAX)
|
Expand Research on NVAX
| Next EPS Date | 8/2/13 *Est. | EPS Growth Rate | -16.7% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -22.9% | Revenue Growth Rate | -18.1% *Last Qtr. |
| Average % Move 1-Wk after EPS | -4.2% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/7/13  |
 |
Q113 | -$0.07 | -$0.06 | -$0.01 | $3.8M | $5.54M | N/A / N/A | N/A | -10.7% | Details |
| 3/1/13 |
|
Q412 | -$0.06 | -$0.04 | -$0.02 | $4.57M | $5.85M | N/A / N/A | N/A | +10.4% | Details |
| 11/2/12 |
|
Q312 | -$0.05 | -$0.04 | -$0.01 | $5.8M | $7.72M | N/A / N/A | N/A | -1% | Details |
| 8/3/12 |
|
Q212 | -$0.05 | -$0.05 | $0.00 | $7.1M | $6.68M | N/A / N/A | N/A | -4.7% | Details |
| 5/4/12 |
|
Q112 | -$0.06 | -$0.04 | -$0.02 | $4.64M | $7.36M | N/A / N/A | N/A | +48.9% | Details |
| 3/9/12 |
|
Q411 | $0.03 | -$0.04 | +$0.07 | $5.85M | $6.87M | N/A / N/A | N/A | +53.4% | Details |
| 11/4/11 |
|
Q311 | -$0.03 | -$0.05 | +$0.02 | $5M | $5.37M | N/A / N/A | N/A | +30.5% | Details |
| 8/5/11 | Q211 | -$0.04 | N/A | N/A | $3M | $2.74M | N/A / N/A | N/A | +28% | Details |
